Pier Vitale Nuzzo received his MD and Ph.D. in Transitional Medicine in Oncology and Hematology from the University of Genoa, Italy. After completing his medical residency in Medical Oncology, he joined the Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute of Boston. He is currently a Postdoctoral Research Fellow at Dana-Farber Cancer Institute, where he is working on clinical and translational research projects in kidney and bladder cancers. Pier Vitale's research is focused on cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq), a non-invasive, cost-effective, and sensitive assay for genome-wide bisulfite-free plasma DNA methylation. He is also mainly focuses on clinical and translational research projects about immunotherapy in genito-urinary cancers.